What if we told you that data could revolutionize healthcare, and in particular, the fight against cancer? You can discover the power of data in our enlightening conversation with Catherine Miller, CTO of Flatiron Health, a seasoned tech expert who transitioned into the healthcare sector. We dive into the profound impact of data analytics and how it can extend lives, inspire drug development, and provide a comprehensive understanding of treatment effects across diverse populations.
The second part of our discussion takes us into the captivating world of AI and machine learning within healthcare. Catherine elucidates how these technologies can decode the vast amounts of unstructured data from electronic health records and aids in extracting critical patient information. She also voices her concerns about the potential risks of AI, underlining the importance of multiple checks on AI models to ensure patient safety. Together, we dissect the pressing issue of data security, a necessity in our current digital age.
Lastly, we grapple with the persistent challenges of efficiency and innovation in healthcare. Catherine offers a wealth of insights into the hurdles faced by clinical trials, including cost implications, time consumption, and potential errors. We also broach the subject of the complex relationship between pharmaceutical companies and health tech companies like Flatiron Health. If you're an entrepreneur trying to break into the healthcare sector, Catherine's practical advice and advocacy for a health equity prioritization lens when building models are indispensable. So, join us on this stimulating journey into the future of health tech.
About Catherine:
Cat Miller is no ordinary CTO. She's been instrumental in transforming the infrastructure of cancer care by harnessing the power of real-world data and incorporating AI into health data analytics. Despite initial skepticism about AI's potential in healthcare, she has led the successful integration of AI into Flatiron's operations, driving forward efficiency and quality of data extraction.
Cat predicts a future where 95% of Flatiron's data could be extracted through AI models, a vision aligned with Flatiron's mission to redefine the boundaries of health data analytics. Cat is also an advocate for the responsible use of AI. As generative AI becomes more widely available and used across the health care landscape, it’s critical that there are standards in place that define high quality data in order to ensure the relevance and reliability of AI’s findings.
https://www.linkedin.com/in/catherine-miller-0177142
